BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22160080)

  • 1. Fanconi anemia.
    Soulier J
    Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.
    Lensch MW; Rathbun RK; Olson SB; Jones GR; Bagby GC
    Leukemia; 1999 Nov; 13(11):1784-9. PubMed ID: 10557053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat MDS and AML in Fanconi anemia.
    Peffault de Latour R; Soulier J
    Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
    Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
    Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
    Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
    Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
    Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R
    Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
    Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular biology of Fanconi anemia.
    Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
    Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
    Vundinti BR; Korgaonkar S; Ghosh K
    Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia: myelodysplasia as a predictor of outcome.
    Alter BP; Caruso JP; Drachtman RA; Uchida T; Velagaleti GV; Elghetany MT
    Cancer Genet Cytogenet; 2000 Mar; 117(2):125-31. PubMed ID: 10704682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fanconi anemia: genes and function(s) revisited].
    Papadopoulo D; Moustacchi E
    Med Sci (Paris); 2005; 21(8-9):730-6. PubMed ID: 16115458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.
    Cioc AM; Wagner JE; MacMillan ML; DeFor T; Hirsch B
    Am J Clin Pathol; 2010 Jan; 133(1):92-100. PubMed ID: 20023263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer in Fanconi anemia, 1927-2001.
    Alter BP
    Cancer; 2003 Jan; 97(2):425-40. PubMed ID: 12518367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.